CREDIT SUISSE AG/ - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 72 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$97,000
+24.4%
17,540
-55.0%
0.00%
Q3 2016$78,000
-47.7%
39,018
+83.7%
0.00%
Q4 2014$149,00021,2370.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,464,807$14,468,0005.57%
COURAGE CAPITAL MANAGEMENT LLC 192,486$1,130,0000.86%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,455$531,0000.07%
Alambic Investment Management, L.P. 86,204$506,0000.07%
Kalos Management, Inc. 30,000$164,0000.05%
Dynamic Technology Lab Private Ltd 32,394$190,0000.03%
ELLINGTON MANAGEMENT GROUP LLC 60,600$356,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 55,008$323,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$129,0000.02%
ACADIAN ASSET MANAGEMENT LLC 580,972$3,411,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders